| Document Date: 2015-01-07 07:26:31
Open Document File Size: 64,91 KBShare Result on Facebook
City Marlborough / Washington / DC / / Company Dainippon Pharmaceutical Co. Ltd. / Sunovion Pharmaceuticals Inc. / BIAL-Portela & Ca S.A. / Sumitomo Pharmaceuticals Co. Ltd. / Sumitomo Dainippon Pharma Co. Ltd. / National Academies Press / Corporate Communications Sunovion Pharmaceuticals Inc. / / Continent North America / Europe / / Country Japan / United States / / / Event FDA Phase / M&A / / Facility Institute of Medicine / / IndustryTerm owned subsidiary / pharmaceutical / healthcare / food / energy / research-based pharmaceutical / heavy machinery / pharmaceutical products / therapeutic products / / MedicalCondition Partial Seizures / double vision / headache / stomach pain / seizures / serious allergic reactions / hives / muscle spasms / nausea / muscle weakness / partialonset seizures / severe seizures / tiredness / infections / sore throat / insomnia / partial-onset seizures / panic attacks / severe fatigue / serious skin rash / complex neurological disorder / mania / muscle pain / fever / seizure / vomiting / frequent infections / Allergic reactions / newly diagnosed epilepsy / Epilepsy / dizziness / depression / Respiratory disease / rash / Disorders / / MedicalTreatment birth control / adjunctive therapy / / Organization Institute of Medicine / APTIOM / U.S. Food and Drug Administration / European Commission / FDA / Epilepsy Foundation / Dartmouth Medical School / / Person Antony Loebel / / / Position Director / Executive Vice President and Chief Medical Officer / / Product primidone / simvastatin / carbamazepine / omeprazole / phenytoin / oxcarbazepine / APTIOM Medication / New Drug Application ® / / ProvinceOrState Massachusetts / / PublishedMedium the APTIOM Medication Guide / / URL www.fda.gov/medwatch / www.ds-pharma.com / www.APTIOM.com / http /
SocialTag |
Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MA[removed]Tel[removed]News Release Contact: